Favipiravir

BDR Receives DCGI Approval for Favipiravir to Treat COVID-19

MUMBAI: BDR Pharmaceuticals –today announced the launch of Favipiravir for the treatment of COVID-19 patients in India. BDR Pharma has…

4 years ago

Glenmark Announces Top-Line Results From Phase 3 Clinical Trial of Favipiravir

KOCHI: Glenmark Pharmaceuticals Ltd. – a global research-led pharmaceutical company - today announced top-line results from a Phase 3 clinical…

4 years ago

Glenmark Commences 1000 Patients Post Marketing Surveillance Study with COVID-19

KOCHI: Glenmark Pharmaceuticals, a research-led, integrated global pharmaceutical company, has announced that it has commenced a Post Marketing Surveillance (PMS)…

4 years ago

Glenmark to Commence Phase 3 Clinical Trial for Moderate COVID-19 in India

KOCHI: Glenmark Pharmaceuticals, a research-led, integrated global pharmaceutical company, has announced a new randomized, open-label study to test the combined…

4 years ago

This website uses cookies.